Company news
Zelira Therapeutics Ltd. news in 2021
Zelira Therapeutics Ltd.'s news releases, calls and decks from 2021, newest first.
Zelira expands into NZ via exclusive distribution agreement
December 15, 2021
ZLD Supports Levins Chronic Pain Trial Ethics Approval
December 1, 2021
Zelira Develops Technology and Signs New Licensing Deal
November 2, 2021
September 2021 Quarterly Activities Report
October 28, 2021
Zelira Raises US$5 Million from US Fund
October 19, 2021
Zelira Launches RAF FIVE Acne Treatment Products
September 22, 2021
Zelira enters Germany via Exclusive Distribution Agreement
September 19, 2021
Appendix 4C - quarterly
July 29, 2021
June 2021 Quarterly Activities Report
July 29, 2021
US Observational Clinical Pain Trial Receives IRB Approval
July 11, 2021
Cantor Fitzgerald - Investor Presentation
June 30, 2021
Research Demonstrates Significant Uptake of CBD Into Brain
June 18, 2021
Zelira to Launch CBD Toothpaste in the United Kingdom
June 14, 2021
ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
June 2, 2021
Zeliras HOPE Range of Products Launches in Washington DC
May 5, 2021
March 2021 Quarterly Report
April 21, 2021
Zelira Announces Record Third Quarter Revenue
April 14, 2021
Appendix 4D & FY21 Interim Financial Report
February 22, 2021
Strategic Transition and Executive Changes
February 14, 2021
December 2020 Quarterly Report
January 28, 2021
Decks in 2021
- Investor Presentation (June 2021)
Investor deck · 17 slides · Jun 30, 2021
- Cantor Presentation (June 2021)
Conference · 17 slides · Jun 29, 2021